KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-Current Debt (2019 - 2025)

GoodRx Holdings' Non-Current Debt history spans 7 years, with the latest figure at $483.3 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 0.71% year-over-year to $483.3 million; the TTM value through Dec 2025 reached $483.3 million, down 0.71%, while the annual FY2025 figure was $483.3 million, 0.71% down from the prior year.
  • Non-Current Debt for Q4 2025 was $483.3 million at GoodRx Holdings, roughly flat from $484.1 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $658.9 million in Q1 2021 and bottomed at $483.3 million in Q4 2025.
  • The 5-year median for Non-Current Debt is $649.2 million (2023), against an average of $602.2 million.
  • The largest annual shift saw Non-Current Debt decreased 0.61% in 2021 before it dropped 24.89% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $655.9 million in 2021, then decreased by 0.62% to $651.8 million in 2022, then decreased by 0.63% to $647.7 million in 2023, then decreased by 24.86% to $486.7 million in 2024, then dropped by 0.71% to $483.3 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Non-Current Debt are $483.3 million (Q4 2025), $484.1 million (Q3 2025), and $485.0 million (Q2 2025).